Catalent Inc Contracts & Agreements

151 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Catalent, Inc. Golden Parachute Excise Tax Reimbursement and Release Agreement
Compensation Agreements
Catalent Inc
Pharmaceuticals
2024
Amendment to Registration Rights Agreement between Catalent, Inc. and Green Equity Investors VII, L.P. et al.
Registration Rights Agreements
Catalent Inc
Pharmaceuticals
2024
Catalent Inc. Special Retention Award Agreement with Employee (2024)
Retention Agreements
Catalent Inc
Pharmaceuticals
DE
2024
Catalent Offer Letter to Michael Hatzfeld for Vice President & Chief Accounting Officer Position
Employment Agreements
Catalent Inc
Pharmaceuticals
2024
Employment Agreement between Catalent, Inc. and John Greisch (Executive Chair)
Employment Agreements
Catalent Inc
Pharmaceuticals
NJ
2024
Termination Agreement between Catalent Pharma Solutions GmbH and Manja Boerman (December 2023)
Termination Agreements
Catalent Inc
Pharmaceuticals
2024
Agreement and Plan of Merger among Creek Parent, Inc., Creek Merger Sub, Inc., and Catalent, Inc. dated February 5, 2024
Merger Agreements
Catalent Inc
Pharmaceuticals
DE
2024
Amendment No. 1 to the Catalent, Inc. 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
2024
Catalent, Inc. Restricted Stock Unit Agreement for Non-Employee Directors under 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2023
Catalent, Inc. Restricted Stock Unit Agreement under 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2023
Catalent, Inc. 2018 Omnibus Incentive Plan Option Agreement with Participant
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2023
Catalent, Inc. Performance Share Unit Agreement under 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2023
Catalent Pharma Solutions Executive Severance Benefits Letter Agreement
Severance Agreements
Catalent Inc
Pharmaceuticals
NJ
2023
Catalent Pharma Solutions, Inc. Executive Severance Benefits Letter Agreement
Severance Agreements
Catalent Inc
Pharmaceuticals
2023
Amended and Restated Employment Offer Letter for Ricky Hopson as President, Clinical Development & Supply, Catalent, Inc.
Employment Agreements
Catalent Inc
Pharmaceuticals
2023
Interim Chief Financial Officer Offer Letter between Catalent, Inc. and Ricky Hopson
Employment Agreements
Catalent Inc
Pharmaceuticals
2023
Interim Stipend Extension Letter between Catalent and Ricky Hopson (August 2023)
Compensation Agreements
Catalent Inc
Pharmaceuticals
2023
Employment Agreement between Catalent Pharma Solutions GmbH and Ms. M. Boerman
Employment Agreements
Catalent Inc
Pharmaceuticals
2023
Catalent Pharma Solutions International Assignment Letter to Manja Boerman (President, Division Head BioModalities)
Employment Agreements
Catalent Inc
Pharmaceuticals
2023
Amendment No. 10 to Amended and Restated Credit Agreement among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, Subsidiary Guarantors, and Lenders
Credit Agreements
Catalent Inc
Pharmaceuticals
NY
2023
Amendment No. 9 to Amended and Restated Credit Agreement among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, Subsidiary Guarantors, and Lenders
Credit Agreements
Catalent Inc
Pharmaceuticals
NY
2023
Cooperation Agreement between Elliott Investment Management L.P. and Catalent, Inc. (August 28, 2023)
Cooperation Agreements
Catalent Inc
Pharmaceuticals
DE
2023
Description of Capital Stock and Related Agreements of Catalent, Inc.
Stock Agreements
Catalent Inc
Pharmaceuticals
DE
2022
Catalent, Inc. FY2023 Management Incentive Plan Summary under 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
2022
Compensation Adjustment Letter for Thomas Castellano from Catalent, Inc.
Compensation Agreements
Catalent Inc
Pharmaceuticals
2022
Catalent Pharma Solutions, Inc. Deferred Compensation Plan (Amended and Restated as of October 1, 2022)
Compensation Agreements
Catalent Inc
Pharmaceuticals
DE
2022
Catalent, Inc. Restricted Stock Unit Agreement under 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2022
Catalent, Inc. Restricted Stock Unit Agreement for Non-U.S. Non-Employee Directors under 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2022
Catalent, Inc. Restricted Stock Unit Agreement under 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2022
Catalent, Inc. Restricted Stock Unit Agreement for Non-U.S. Participants under 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2022
Catalent, Inc. 2018 Omnibus Incentive Plan Option Agreement with Participant
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2022
Catalent, Inc. 2018 Omnibus Incentive Plan Option Agreement for Non-U.S. Participants
Equity Distribution Agreements
Catalent Inc
Pharmaceuticals
NJ
2022
Catalent, Inc. 2018 Omnibus Incentive Plan Performance Share Unit Agreement (2022–2025)
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2022
Catalent, Inc. Performance Share Unit Agreement for Non-U.S. Participants under 2018 Omnibus Incentive Plan (2022–2025)
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2022
Catalent Offer Letter for Vice President and Chief Accounting Officer – Karen Santiago
Employment Agreements
Catalent Inc
Pharmaceuticals
2022
Catalent Pharma Solutions Executive Employment Offer Letter Amendment with Aristippos Gennadios
Employment Agreements
Catalent Inc
Pharmaceuticals
2022
Catalent, Inc. Executive Vice President and Chief Administrative Officer Employment Offer Letter with Steven Fasman (Amended and Restated)
Employment Agreements
Catalent Inc
Pharmaceuticals
2022
Catalent, Inc. Amended and Restated Employment Offer Letter to Aris Gennadios (Group President, Pharma & Consumer Health)
Employment Agreements
Catalent Inc
Pharmaceuticals
2022
Employment Agreement between Catalent, Inc. and Alessandro Maselli (CEO Appointment)
Employment Agreements
Catalent Inc
Pharmaceuticals
NJ
2022
Amended and Restated Employment Agreement between Catalent, Inc. and John R. Chiminski
Employment Agreements
Catalent Inc
Pharmaceuticals
DE
2022
Catalent, Inc. FY2022 Management Incentive Plan Summary under 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
2021
Indenture Agreement for 3.500% Senior Notes Due 2030 among Catalent Pharma Solutions, Inc., Guarantors, and Deutsche Bank Trust Company Americas
Indenture Agreements
Catalent Inc
Pharmaceuticals
NY
2021
Membership Interest Purchase Agreement among Catalent Pharma Solutions, Inc., Bettera Holdings, LLC, and Members
Purchase Agreements
Catalent Inc
Pharmaceuticals
DE
2021
Catalent, Inc. Employment Offer Letter for Ricky Hopson as VP & Chief Accounting Officer
Employment Agreements
Catalent Inc
Pharmaceuticals
2021
Amended and Restated Employment Offer Letter for SVP & CFO Tom Castellano – Catalent Pharma Solutions, Inc.
Employment Agreements
Catalent Inc
Pharmaceuticals
2021
Indenture for 3.125% Senior Notes Due 2029 among Catalent Pharma Solutions, Inc., Guarantors, and Deutsche Bank Trust Company Americas
Indenture Agreements
Catalent Inc
Pharmaceuticals
NY
2021
Catalent, Inc. FY2021 Management Incentive Plan Summary under 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
2020
Catalent Offer Letter to Karen for President, Biologics and Chief Commercial Officer Position
Employment Agreements
Catalent Inc
Pharmaceuticals
2020
Catalent, Inc. Restricted Stock Unit Agreement under 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2020
Second Amendment to Employment Agreement between Catalent, Inc. and John R. Chiminski
Employment Agreements
Catalent Inc
Pharmaceuticals
DE
2020
Underwriting Agreement between Catalent, Inc. and RBC Capital Markets, LLC for Common Stock Offering (June 10, 2020)
Underwriting Agreements
Catalent Inc
Pharmaceuticals
2020
Indenture for 2.375% Senior Notes Due 2028 among Catalent Pharma Solutions, Inc., Guarantors, and Deutsche Trustee Company Limited
Indenture Agreements
Catalent Inc
Pharmaceuticals
DE
2020
Catalent, Inc. Common Stock Underwriting Agreement with J.P. Morgan Securities LLC and UBS Securities LLC (February 2020)
Underwriting Agreements
Catalent Inc
Pharmaceuticals
2020
Stock Purchase Agreement among Orgenesis Inc., GPP-II Masthercell, LLC, Masthercell Global Inc., and Catalent Pharma Solutions, Inc. dated February 2, 2020
Purchase Agreements
Catalent Inc
Pharmaceuticals
DE
2020
Catalent, Inc. Performance Share Unit Agreement under 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2019
Catalent, Inc. Performance Share Unit Agreement for Non-U.S. Participants under 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2019
Catalent, Inc. FY2020 Management Incentive Plan Summary under 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
2019
First Amendment to Agreement and Plan of Merger between Catalent Pharma Solutions, Inc. and Paragon Bioservices, Inc.
Merger Agreements
Catalent Inc
Pharmaceuticals
2019
Catalent, Inc. Description of Capital Stock as of June 30, 2019
Stock Agreements
Catalent Inc
Pharmaceuticals
DE
2019
Catalent Pharma Solutions Promotion and Employment Terms Letter for Alessandro Maselli
Employment Agreements
Catalent Inc
Pharmaceuticals
2019
Catalent Pharma Solutions Senior Vice President Employment Agreement with Alessandro Maselli
Employment Agreements
Catalent Inc
Pharmaceuticals
2019
Amended Executive Offer Letter for Senior Vice President and General Counsel – Catalent Pharma Solutions and Steven Fasman
Employment Agreements
Catalent Inc
Pharmaceuticals
2019
Rollover Agreement between Catalent, Inc. and Peter Buzy Regarding Stock Option Conversion Related to Paragon Bioservices Merger
Merger Agreements
Catalent Inc
Pharmaceuticals
NJ
2019
Catalent Pharma Solutions, Inc. Employment Offer Letter to Pete Buzy (President, Gene Therapy)
Employment Agreements
Catalent Inc
Pharmaceuticals
2019
Catalent, Inc. 2018 Omnibus Incentive Plan Nonqualified Stock Option Grant to Peter L. Buzy
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
2019
Catalent, Inc. Nonqualified Stock Option Grant and Substitute Option Agreement with Peter L. Buzy under 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2019
Catalent, Inc. FY2019 Management Incentive Plan Summary under 2014 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
2019
Indenture Agreement for 5.00% Senior Notes Due 2027 among Catalent Pharma Solutions, Inc., Guarantors, and Deutsche Bank Trust Company Americas
Indenture Agreements
Catalent Inc
Pharmaceuticals
NY
2019
Stockholders’ Agreement among Catalent, Inc. and Green Equity Investors Entities dated May 17, 2019
Shareholders Agreements
Catalent Inc
Pharmaceuticals
DE
2019
Registration Rights Agreement between Catalent, Inc. and Green Equity Investors VII, L.P. et al. dated May 17, 2019
Registration Rights Agreements
Catalent Inc
Pharmaceuticals
NY
2019
Catalent, Inc. Restricted Stock Unit Agreement under 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2019
Catalent, Inc. Restricted Stock Unit Agreement for Non-U.S. Participants under 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2019
Catalent, Inc. Performance Share Unit Agreement under 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2019
Catalent, Inc. Performance Share Unit Agreement for Non-U.S. Participants under 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2019
Catalent, Inc. Option Agreement under 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2019
Catalent, Inc. 2018 Omnibus Incentive Plan Non-U.S. Participant Stock Option Agreement
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2019
Agreement and Plan of Merger among Catalent Pharma Solutions, Inc., Catalent Holdco I Inc., Paragon Bioservices, Inc., and Others (April 14, 2019)
Merger Agreements
Catalent Inc
Pharmaceuticals
DE
2019
Equity Commitment and Investment Agreement between Catalent, Inc. and Green Equity Investors VII, L.P. and Green Equity Investors Side VII, L.P. dated April 14, 2019
Investment Agreements
Catalent Inc
Pharmaceuticals
NY
2019
Catalent, Inc. 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
DE
2019
Catalent, Inc. Management Incentive Plan (MIP) Summary Plan Description for FY2018
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
2018
Catalent, Inc. 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
DE
2018
Catalent, Inc. 2019 Employee Stock Purchase Plan
Stock Agreements
Catalent Inc
Pharmaceuticals
DE
2018
Catalent, Inc. Performance Restricted Stock Agreement under 2014 Omnibus Incentive Plan (2016–2019)
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2018
Catalent, Inc. Performance Restricted Stock Agreement under 2014 Omnibus Incentive Plan (2016–2019)
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2018
Catalent, Inc. Performance Restricted Stock Agreement under 2014 Omnibus Incentive Plan (2017–2020)
Compensation Agreements
Catalent Inc
Pharmaceuticals
NJ
2018
Catalent, Inc. Performance Restricted Stock Agreement under 2014 Omnibus Incentive Plan (2017–2020)
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2018
Catalent, Inc. Performance Share Unit Agreement under 2014 Omnibus Incentive Plan (2018–2021)
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2018
Catalent, Inc. Performance Share Unit Agreement for Non-U.S. Participants under 2014 Omnibus Incentive Plan (2018–2021)
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2018
Catalent, Inc. Performance Restricted Stock Agreement under 2014 Omnibus Incentive Plan (2018–2021)
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2018
Catalent, Inc. Performance Restricted Stock Agreement under 2014 Omnibus Incentive Plan (2018–2021)
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2018
Catalent Pharma Solutions, Inc. Executive Employment Offer Letter to Jonathan Arnold (President, Oral Drug Delivery)
Employment Agreements
Catalent Inc
Pharmaceuticals
2018
Employment Agreement between Catalent Pharma Solutions GmbH and Jonathan Arnold
Employment Agreements
Catalent Inc
Pharmaceuticals
2018
Catalent, Inc. FY2018 Management Incentive Plan Summary Description
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
2018
Catalent, Inc. Common Stock Underwriting Agreement with J.P. Morgan, Morgan Stanley, and RBC Capital Markets (July 24, 2018)
Underwriting Agreements
Catalent Inc
Pharmaceuticals
2018
Agreement and Plan of Merger among Catalent Pharma Solutions, Inc., Catalent Boston, Inc., and Juniper Pharmaceuticals, Inc. (July 2, 2018)
Merger Agreements
Catalent Inc
Pharmaceuticals
DE
2018
Catalent Pharma Solutions, LLC Senior Vice President, Chief Financial Officer Employment Offer Letter with Wetteny Joseph
Employment Agreements
Catalent Inc
Pharmaceuticals
2018
Catalent Pharma Solutions, Inc. Deferred Compensation Plan (Amended and Restated Effective January 1, 2016)
Compensation Agreements
Catalent Inc
Pharmaceuticals
DE
2017
Amendment No. 2 to Catalent Pharma Solutions, Inc. Deferred Compensation Plan
Retirement Agreements
Catalent Inc
Pharmaceuticals
2017
Catalent, Inc. Performance Share Unit Agreement under 2014 Omnibus Incentive Plan (2017–2020)
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2017
Catalent, Inc. Performance Share Unit Agreement for Non-U.S. Participants under 2014 Omnibus Incentive Plan (2017–2020)
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2017
Indenture for 4.875% Senior Notes Due 2026 among Catalent Pharma Solutions, Inc., Guarantors, and Deutsche Bank Trust Company Americas
Indenture Agreements
Catalent Inc
Pharmaceuticals
NY
2017
Amendment No. 3 to Amended and Restated Credit Agreement among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, and Lenders
Credit Agreements
Catalent Inc
Pharmaceuticals
KS
2017
Underwriting Agreement between Catalent, Inc. and Morgan Stanley, J.P. Morgan, and RBC Capital Markets (September 26, 2017)
Underwriting Agreements
Catalent Inc
Pharmaceuticals
2017
Interest Purchase Agreement among Catalent Pharma Solutions, Inc., Cook Pharmica LLC, and Cook Group Incorporated (September 18, 2017)
Purchase Agreements
Catalent Inc
Pharmaceuticals
DE
2017
Amendment to Catalent Pharma Solutions, Inc. Deferred Compensation Plan (Effective January 1, 2017)
Compensation Agreements
Catalent Inc
Pharmaceuticals
2017
Catalent, Inc. Management Incentive Plan (MIP) Summary Plan Description for FY2017
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
2017
Catalent Pharma Solutions Employment Offer Letter to Barry Littlejohns (President, Medical Delivery Systems)
Employment Agreements
Catalent Inc
Pharmaceuticals
2017
Catalent, Inc. Performance Share Unit Agreement under 2014 Omnibus Incentive Plan (2016–2019)
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2017
Catalent, Inc. Performance Share Unit Agreement for Non-U.S. Participants under 2014 Omnibus Incentive Plan (2016–2019)
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2017
Settlement Agreement between Catalent Pharma Solutions Limited and Sharon Johnson (May 2017)
Settlement Agreements
Catalent Inc
Pharmaceuticals
2017
Amendment to Employment Agreement between Catalent, Inc. and John R. Chiminski (August 23, 2017)
Employment Agreements
Catalent Inc
Pharmaceuticals
DE
2017
Catalent, Inc. Restricted Stock Grant Agreement under 2014 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2017
Catalent, Inc. Performance Restricted Stock Grant Agreement under 2014 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2017
Indenture for 4.750% Senior Notes Due 2024 among Catalent Pharma Solutions, Inc., Guarantors, and Deutsche Trustee Company Limited
Indenture Agreements
Catalent Inc
Pharmaceuticals
DE
2016
Amendment No. 2 to Amended and Restated Credit Agreement among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, and Morgan Stanley Senior Funding, Inc.
Credit Agreements
Catalent Inc
Pharmaceuticals
NY
2016
Catalent, Inc. Common Stock Underwriting Agreement with Goldman Sachs, Deutsche Bank, and Morgan Stanley (2016)
Underwriting Agreements
Catalent Inc
Pharmaceuticals
2016
Catalent Pharma Solutions, Inc. Employment Offer Letter to Steven Fasman (Senior Vice President and General Counsel)
Employment Agreements
Catalent Inc
Pharmaceuticals
2016
Catalent, Inc. Performance Share Unit Agreement under 2014 Omnibus Incentive Plan (2015–2018)
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2016
Catalent, Inc. Performance Share Unit Agreement for Non-U.S. Participants under 2014 Omnibus Incentive Plan (2015–2018)
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2016
Catalent, Inc. Management Incentive Plan Summary Plan Description for FY2016
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
2016
Catalent Pharma Solutions, Inc. Deferred Compensation Plan (Amended and Restated as of January 1, 2016)
Compensation Agreements
Catalent Inc
Pharmaceuticals
DE
2016
Catalent, Inc. and Selling Stockholders Underwriting Agreement with Goldman, Sachs & Co. (June 6, 2016)
Underwriting Agreements
Catalent Inc
Pharmaceuticals
2016
Catalent, Inc. Performance Share Unit Grant Notice and Agreement under 2014 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2015
Catalent, Inc. Performance Share Unit Grant Agreement for Non-U.S. Participants under 2014 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2015
International Assignment Agreement between Catalent Pharma Solutions and Will (Senior Vice President, Global Sales & Marketing)
Employment Agreements
Catalent Inc
Pharmaceuticals
2015
Catalent Pharma Solutions Employment Offer Letter to Steve Leonard (Senior Vice President, Global Operations)
Employment Agreements
Catalent Inc
Pharmaceuticals
2015
Catalent Pharma Solutions Terms and Conditions of Employment for Sharon Johnson (SVP, Global Quality)
Employment Agreements
Catalent Inc
Pharmaceuticals
2015
Employment Agreement Letter between Catalent Pharma Solutions and Sharon Johnson (April 6, 2011)
Employment Agreements
Catalent Inc
Pharmaceuticals
2015
Catalent Pharma Solutions International Assignment Relocation Benefits Letter to Sharon Johnson (June 18, 2013)
Employment Agreements
Catalent Inc
Pharmaceuticals
2015
Catalent, Inc. Common Stock Underwriting Agreement with Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC (2015)
Underwriting Agreements
Catalent Inc
Pharmaceuticals
2015
Catalent, Inc. Common Stock Underwriting Agreement with Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC (2015)
Underwriting Agreements
Catalent Inc
Pharmaceuticals
2015
Amendment No. 1 to Credit Agreement among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, and Lenders
Credit Agreements
Catalent Inc
Pharmaceuticals
NY
2014
Catalent, Inc. Performance Share Unit Grant Notice and Agreement under 2014 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2014
Catalent, Inc. Performance Share Unit Grant Notice and Agreement for Non-U.S. Participants under 2014 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2014
Employment Agreement between Catalent, Inc. and John R. Chiminski
Employment Agreements
Catalent Inc
Pharmaceuticals
DE
2014
Stockholders Agreement between Catalent, Inc. and Blackstone Healthcare Partners L.L.C. dated August 5, 2014
Shareholders Agreements
Catalent Inc
Pharmaceuticals
DE
2014
Registration Rights Agreement by and among Catalent, Inc., Blackstone, Genstar Phoenix Holdings, LLC, Aisling Capital II, L.P., and Management Stockholders (August 5, 2014)
Registration Rights Agreements
Catalent Inc
Pharmaceuticals
NY
2014
Catalent, Inc. 2014 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
DE
2014
Catalent, Inc. 2014 Omnibus Incentive Plan Option Grant Notice and Agreement
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2014
Catalent, Inc. Restricted Stock Unit Grant Agreement under 2014 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2014
Catalent, Inc. Restricted Stock Unit Grant Agreement for Non-Employee Directors under 2014 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2014
Catalent, Inc. Non-U.S. Stock Option Grant Agreement under 2014 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2014
Catalent, Inc. Restricted Stock Unit Grant Agreement for Non-U.S. Participants under 2014 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
NJ
2014
Registration Rights Agreement by and among Catalent, Inc. and Certain Stockholders (2014)
Registration Rights Agreements
Catalent Inc
Pharmaceuticals
NY
2014
Catalent, Inc. Underwriting Agreement with Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC (2014)
Underwriting Agreements
Catalent Inc
Pharmaceuticals
2014
Catalent, Inc. 2014 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
DE
2014
Catalent, Inc. 2014 Omnibus Incentive Plan Nonqualified Stock Option Grant Agreement
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
DE
2014
Catalent, Inc. Restricted Stock Unit Grant Agreement under 2014 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
DE
2014
Catalent, Inc. Non-Employee Director Restricted Stock Unit Grant Agreement under 2014 Omnibus Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
DE
2014
Stockholders Agreement among Catalent, Inc., Blackstone Healthcare Partners L.L.C., and Phoenix Charter LLC (2014)
Shareholders Agreements
Catalent Inc
Pharmaceuticals
DE
2014
Amendment No. 2 to the 2007 PTS Holdings Corp. Stock Incentive Plan
Bonus & Incentive Agreements
Catalent Inc
Pharmaceuticals
2014